Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

HEPA Hepion Pharmaceuticals Inc

1,26

-0,05 (-3,82%)

11 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Hepion Pharmaceuticals Charts.

Hepion Pharmaceuticals (NASDAQ:HEPA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Hepion Pharmaceuticals Charts.

News Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Freitag 19 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 16 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
Freitag 16 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Hepion Pharmaceuticals to Present at NASH-TAG 2024
Mittwoch 3 Januar 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 3 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
Donnerstag 7 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
Dienstag 28 November 2023 (5 Monate vor) • GlobeNewswire Inc.

Hepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
Montag 13 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
Freitag 10 November 2023 (6 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Donnerstag 9 November 2023 (6 Monate vor) • Edgar (US Regulatory)

Hepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
Mittwoch 25 Oktober 2023 (7 Monate vor) • GlobeNewswire Inc.

Weitere Hepion Pharmaceuticals Inc News-Artikel

Health Care Select Sector

Energy Select Sector SPDR

Euro vs Sterling

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen